Risk factors for discontinuation of insulin pump therapy in pediatric and young adult patients

Primary Care Diabetes - Tập 8 - Trang 346-351 - 2014
Karel Kostev1, Timo Rockel1, Joachim Rosenbauer2, Wolfgang Rathmann2
1IMS HEALTH, D-60598 Frankfurt/Main, Germany
2Institute for Biometrics and Epidemiology, German Diabetes Center, D-40225 Duesseldorf, Germany

Tài liệu tham khảo

Kordonouri, 2011, Treatment of type 1 diabetes in children and adolescents using modern insulin pumps, Diabetes Res. Clin. Pract., 93, S118, 10.1016/S0168-8227(11)70027-4

Rosenbauer, 2012, Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multi-center data from Germany and Austria, Diabetes Care, 35, 80, 10.2337/dc11-0993

Hofer, 2010, Discontinuation of insulin pump treatment in children, adolescents, and young adults: a multicenter analysis based on the DPV database in Germany and Austria, Pediatr. Diabetes, 11, 116, 10.1111/j.1399-5448.2009.00546.x

Hofer, 2012, Insulin pump treatment in children and adolescents with type 1 diabetes, Minerva Pediatr., 64, 433

de Vries, 2011, Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes, Pediatr. Diabetes, 12, 506, 10.1111/j.1399-5448.2010.00701.x

Wood, 2006, Durability of insulin pump use in pediatric patients with type 1 diabetes, Diabetes Care, 29, 2355, 10.2337/dc06-1141

Kordonouri, 2002, Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey, Diabetes Care, 25, 1346, 10.2337/diacare.25.8.1346

Fröhlich-Reiterer, 2008, Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus – data from a German/Austrian multicentre survey, Pediatr. Diabetes, 9, 546, 10.1111/j.1399-5448.2008.00435.x

Kordonouri, 2009, Other complications and conditions associated with diabetes in children and adolescents, Pediatr. Diabetes, 10, 204, 10.1111/j.1399-5448.2009.00573.x

Warncke, 2010, Polyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28,671 patients from the German/Austrian DPV-Wiss database, Diabetes Care, 33, 2010, 10.2337/dc10-0404

Hamer, 2012, Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany – a nationwide population-based study in children and adults, J. Neurol., 259, 2376, 10.1007/s00415-012-6509-3

Burek, 1990, Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives, Autoimmunity, 7, 157, 10.3109/08916939008993388

Ramakrishnan, 2012, Study of prevalence of epilepsy in children with type 1 diabetes mellitus, Seizure, 21, 292, 10.1016/j.seizure.2012.01.003

Verrotti, 2012, Seizures and type 1 diabetes mellitus: current state of knowledge, Eur. J. Endocrinol., 167, 749, 10.1530/EJE-12-0699

Schober, 2012, Association of epilepsy and type 1 diabetes mellitus in children and adolescents: is there an increased risk for diabetic ketoacidosis?, J. Pediatr., 160, 662, 10.1016/j.jpeds.2011.09.054

Rice, 2006, Choosing and using an insulin pump infusion set, Diabetes Self Manage., 23, 62

Neu, 2013, Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter, Diabetologie, 8, S189, 10.1055/s-0033-1350564

Thông tin
Thông tin xuất bản

Primary Care Diabetes

Tập 8

346-351

Thông tin tác giả